Mindpeak's AI Comes out on Top in Comparative Study on HER2-low Scoring by Cypath and Institut Gustave Roussy

In a first of its kind comparative study, Mindpeak's CE-marked HER2 AI for breast cancer diagnosis was compared to three other commercial AIs (e.g. Visiopharm). Mindpeak's AI showed the highest accuracy

Related Keywords

Canada ,United States ,Canadian ,Carsten Maltzan ,Institut Gustave Roussy ,Astrazeneca ,Canadian Academy Of Pathology ,Canadian Academy ,New Orleans ,Mindpeak Breast ,Business Wire ,Mindpeak ,Homes ,Comparative ,Study ,Ther2 ,Scoring ,Mypath ,Institut ,Gustave ,Moussy ,